RxDoctor Payments DataLook up a doctor →

Betsy Dodson, PA

Physician Assistant · Grapevine, TXNPI 1912988999

Payments from drug & device makers

$104,140in general payments, 2019–2025

Across 570 payments — averaging $182.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Phathom Pharmaceuticals, Inc.$94K
  • AbbVie$2K
  • Johnson & Johnson$1K
  • Ardelyx, Inc.$864
  • Takeda Pharmaceuticals U.S.A., Inc.$814
  • Janssen Scientific Affairs, LLC$808
  • plus $4K from 28 others

What the payments were for

  • Consulting fees$5100%
  • Speaking & faculty fees$68,36866%
  • Travel & lodging$21,07620%
  • Food & beverage$14,02213%
  • Education$1640%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$104,140 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$143,777
Medicare patients
350
Services billed
5,046

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide25$32,315
Mesalamine23$10,844
Pantoprazole Sodium334$4,783
Omeprazole211$4,041
Esomeprazole Magnesium100$4,028
Desipramine Hcl61$3,016
Ursodiol11$2,503
Budesonide DrBudesonide14$868
Dicyclomine Hcl41$626
Ondansetron OdtOndansetron24$433
Amitriptyline Hcl34$352
Nortriptyline Hcl13$174
Sertraline Hcl17$124

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$2,222$32,31525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Grapevine

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →